Thermo Fisher Scientific INC Form 4 insider transactions

Director Tyler Jacks reports acquiring 339 shares of Thermo Fisher Scientific stock and disposing of 8,398 shares on May 22, 2024.

Director R. Alexandra Keith reports acquisition and disposal of Thermo Fisher Scientific (TMO) common stock on May 22, 2024.

Director Debora L. Spar reported the disposition of common stock in Thermo Fisher Scientific Inc. on May 22, 2024.

Director James C. Mullen reported the acquisition and disposal of Thermo Fisher Scientific (TMO) common stock on May 22, 2024.

Director Scott Sperling reports acquisition and disposal of Thermo Fisher Scientific shares on May 22, 2024.

Director Dion J. Weisler reports changes in beneficial ownership of Thermo Fisher Scientific Inc. stock, including acquisitions and disposals, as per a Form 4 filing with the SEC.

Michel Lagarde, Executive Vice President & COO of Thermo Fisher Scientific, exercised stock options and sold 20,000 shares of common stock on May 14, 2024.

Stephen Williamson, CFO of Thermo Fisher Scientific, executed stock transactions including option exercises and share transfers to a Spousal Lifetime Access Trust (SLAT).

Joseph R. Holmes, VP & Chief Accounting Officer of Thermo Fisher Scientific, disposed of shares to cover tax obligations arising from vested stock.

Executive Vice President Frederick M. Lowery reports changes in beneficial ownership of Thermo Fisher Scientific stock, including the disposition of shares to cover tax obligations.

Executive Vice President Gianluca Pettiti of Thermo Fisher Scientific reported a transaction involving common stock on May 5, 2024.

Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares on May 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Thermo Fisher Scientific's CEO, Marc N. Casper, exercised stock options and sold shares of common stock on April 29 and 30, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Michael A. Boxer, SVP and General Counsel of Thermo Fisher Scientific, exercised stock options and sold 2,000 shares of common stock at $567.94 per share on April 26, 2024, under a pre-arranged 10b5-1 trading plan.

Director R. Alexandra Keith acquired phantom stock units in Thermo Fisher Scientific through the company's Deferred Compensation Plan for Directors.

Scott M. Sperling, a director of Thermo Fisher Scientific, reported the acquisition of stock units under the company's Deferred Compensation Plan for Directors.

Director Dion J. Weisler reports acquisition of phantom stock units and holdings in Thermo Fisher Scientific.

Director Jennifer M. Johnson reported the acquisition of phantom stock units in Thermo Fisher Scientific Inc. through the company's Deferred Compensation Plan for Directors.

Joseph R. Holmes, VP & Chief Accounting Officer of Thermo Fisher Scientific, reports the acquisition and disposal of common stock on March 25, 2024.

Thermo Fisher Scientific and related entities report the disposition of 868,990 shares of Science 37 Holdings common stock at $5.75 per share following a reverse stock split.

Thermo Fisher Scientific and related entities report the disposition of Science 37 Holdings common stock at $5.75 per share following a 1-for-20 reverse stock split.

Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares on March 13, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Thermo Fisher Scientific's CEO, Marc N. Casper, exercised stock options and sold shares of common stock on March 11 and 12, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Lisa P. Britt, a Senior VP and Chief HR Officer at Thermo Fisher Scientific, exercised stock options and sold shares of common stock on March 12, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares on February 29, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares of common stock on February 27 and 28, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Michael A. Boxer, SVP and General Counsel of Thermo Fisher Scientific, reported the disposal of 291.068 shares of common stock on February 28, 2024, to cover tax obligations.

Joseph R. Holmes, VP & Chief Accounting Officer of Thermo Fisher Scientific, disposed of shares to cover tax obligations arising from vesting of restricted stock units.

Gianluca Pettiti, Executive Vice President of Thermo Fisher Scientific, reported the disposal of 705.429 shares of common stock to cover tax obligations.

Stephen Williamson, Sr. VP and CFO of Thermo Fisher Scientific, reported a transaction involving common stock on February 28, 2024.